Epidemiologic Shift in Candidemia Driven by <i>Candida auris</i>, South Africa, 2016–20171Erika van Schalkwyk, Ruth Mpembe, Juno Thomas et al.|Emerging infectious diseases|2019Cited by 138
The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspectiveShamshul Ansari, Enrique Castro‐Sánchez, John P. Hays et al.|JAC-Antimicrobial Resistance|2021Cited by 106
Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South AfricaSusan Meiring, Andrew Whitelaw, Stefano Tempia et al.|Clinical Infectious Diseases|2022Cited by 65
Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS studyAislinn Cook, Daniel Jarovsky, Ravinder Kaur et al.|Medical Mycology|2023Cited by 61
Outcomes of flucytosine-containing combination treatment for cryptococcal meningitis in a South African national access programme: a cross-sectional observational studyRudzani Mashau, Nomonde Dlamini, Susan Meiring et al.|The Lancet Infectious Diseases|2022Cited by 24